✦ LIBER ✦

Application of cancer procoagulant as an early detection tumor marker

✍ Scribed by Diane L. Kozwich; Leslie C. Kramer; Wojciech P. Mielicki; Sophia S. Fotopoulos; Stuart G. Gordon

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 889 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940815)74:4<1367::aid-cncr2820740430>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oncogenes as markers for early detection

Oncogenes as markers for early detection of cancer

✍ Geoffrey M. Cooper 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Oncogenes are formed in human tumors as a result of mutations or DNA rearrangements leading to the abnormal expression or function of proto-oncogenes. Approximately 20 different oncogenes are reproducibly activated in malignancies of several types, including breast, colon, lung, pancreatic, and thyr

An evaluation of markers in the early de

An evaluation of markers in the early detection of large bowel cancer

✍ Dr. Morton K. Schwartz 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 2 views

RASSF1A is not appropriate as an early d

RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer

✍ Naeyun Choi; Dae-Soon Son; Inseung Song; Hye-Sook Lee; Yoo-Sung Lim; Min Sup Son 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 329 KB 👁 1 views

## Abstract Aberrant methylation of several tumor suppressor genes often occurs during the pathogenesis of lung cancer. RASSF1A is one of the tumor suppressor genes, and it is frequently inactivated by hypermethylation of its promoter region in a variety of human cancers, including lung cancer. It

Ovarian cancer screening. The use of ser

Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection

✍ Jonathan S. Berek; Robert C. Bast 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

Erythrocyte sedimentation rate as a tumo

Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer. An analysis of prognostic factors in 300 population-based consecutive cases

✍ Jan-Erik Johansson; Theodor Sigurdsson; Lars Holmberg; Reinhold Bergstrom 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

## Background: The natural history of prostatic cancer is variable. our knowledge of prognostic factors is limited; therefore, research is needed. ## Methods: The cases of 300 population-based consecutive patients with a diagnosis of cancer of the prostate were analyzed regarding different progno

High tumor tissue concentration of plasm

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer

✍ Johanna Nordengren; Margareta Fredstorp Lidebring; Pär-Ola Bendahl; Nils Brünner 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB 👁 1 views

## Abstract Previous studies including various tumor types have shown different associations between tumor tissue levels of plasminogen activator inhibitor 2 (PAI‐2) and patient survival. High tumor tissue concentrations of PAI‐2 have been associated with good prognosis in patients with breast canc